SME · BSESubscribed: 2.55×GMP ₹3
Shanmuga Hospital Limited

Shanmuga Hospital Limited

Shanmuga Hospital Limited(SHANMUGA)

Total Shares

38,18,000

Issue Size

₹20.62 Cr

Price Band

54 – ₹54

Lot Size

2000 shares

Min. Investment

1,08,000

Max. Investment

1,08,000

Open Date

13 Feb, 2025

Close Date

17 Feb, 2025

Allotment

18 Feb, 2025

Listing

20 Feb, 2025

Announced

13 Feb, 2025

Opening Date

13 Feb, 2025

Closing Date

17 Feb, 2025

Basis of Allotment

18 Feb, 2025

Initiation of Refunds

19 Feb, 2025

Credit of Shares

19 Feb, 2025

Listing Date

20 Feb, 2025

Live GMP

Est. Listing: ₹62

8

Apply via UPI in 5 minutes

Choose your broker • Zero commission on IPO

About Shanmuga Hospital Limited IPO

Incorporated in 2020, Shanmuga Hospital Limited is a Multispecialty Hospital.

Shanmuga Hospital is equipped with advanced healthcare technology and having 151 bed capacity, it addresses the community’s medical needs, serving patients from nearby regions.

Accredited by NABH and NABL, the hospital is dedicated to providing high-quality healthcare services, including prevention, treatment, and rehabilitation.

Located at 51/24 Saradha College Road, Salem, Tamil Nadu, the hosp

Shanmuga Hospital Limited IPO Share Price and Issue Size

Issue Breakdown

Total Issue38,18,000 shares₹20.62 Cr
Fresh Issue38,18,000 shares₹20.62 Cr
Offer for Sale0 shares

Shareholding

Pre-Issue97,95,000
Post-Issue1,36,13,000

Dilution: 39.0% increase in shares

Shanmuga Hospital Limited IPO Financials Health

Shanmuga Hospital Limited IPO Lot Size

ApplicationLotsSharesAmount
Retail Minimum120001,08,000
Retail Maximum120001,08,000
HNI Minimum240002,16,000

(All values in CR)

Shanmuga Hospital Limited IPO Valuation

MetricValue
DEBT/EQUITY0.53
EPS Post IPO4.75
EPS Pre IPO5.37
P/E Post IPO11.36
P/E Pre IPO10.05
PAT MARGIN12.13
PRICE TO BOOK VALUE3.09
ROCE35.89%
ROE30.71%
RONW30.71%

(All values in CR)

Strength & Risk of Shanmuga Hospital Limited IPO

+Strengths

1. Established and proven track record.

2. Leveraging the experience of our Promoters.

3. Experienced management team and a motivated and efficient work force.

4. Cordial relations with our customers.

5. Quality Assurance & Control.

!Risks

1. Our Company, Directors, Promoters and Group Companies are parties to certain legal proceedings. Any adverse decision in such proceedings may have a material adverse effect on our business, results of operations and financial condition

2. Our Company has limited operating history, and therefore investors may not be able to assess our prospects on the basis of historical results.

3. We are highly dependent on our healthcare professionals, including doctors, nurses that we engage on a consultancy basis, and our business and financial results could be impacted if we are not able to attract and retain such healthcare professionals.

4. Our Company is yet to place orders for medical equipment proposed to be installed at our hospital. Any delay in placing orders or procurement of such equipment may delay the schedule of implementation and possibly increase the cost of commencing operations.

5. We generate certain revenues from the arrangements with government sponsored health schemes, any adverse change in these regulations/government policies related to such schemes may adversely affect our business, results of operations, cash flows and prospects.

6. Delay in receipt of payment from our patients / customers may affect our cash flows, which may, in turn affect our financial condition and results of operations.

7. Our indebtedness and the conditions and restrictions imposed by our financing arrangements may limit our ability to grow our business and adversely impact our business.

8. Changes in healthcare laws, rules and regulations may materially adversely affect our business

9. Our Company had negative cash flow in recent fiscals, details of which are given below. Sustained negative cash flow could adversely impact our business, financial condition and results of operations.

10. There are certain instances of delays in the past with ROC/Statutory Authorities.

Shanmuga Hospital Limited IPO Subscription Status

Investor CategorySubscription (times)Shares OfferedShares bid forTotal Amount (Rs Cr.)
HNI0.7118,12,00012,86,0006.94
Market Maker1.001,92,0001,92,0001.04
Retail4.3918,14,00079,70,00043.04
Total2.5536,26,00092,56,00049.98

Shanmuga Hospital Limited IPO GMP

+8+14.8%

Last updated 10 Feb, 2025 · Source: aggregated grey-market dealers

DateIPO PriceGMPSub2 SaudaEst. ListingEst. ProfitUpdated
10 Feb, 202554₹812200₹62 (14.81%)-10 Feb, 2025
11 Feb, 202554₹812200₹62 (14.81%)-11 Feb, 2025
12 Feb, 202554₹812200₹62 (14.81%)-12 Feb, 2025
13 Feb, 202554₹812200₹62 (14.81%)-13 Feb, 2025
17 Feb, 202554₹34600₹57 (5.56%)-17 Feb, 2025
18 Feb, 202554₹34600₹57 (5.56%)-18 Feb, 2025
20 Feb, 202554₹34600₹57 (5.56%)-20 Feb, 2025

Disclaimer: GMP is an unofficial signal from grey-market dealers and is not regulated by SEBI. Use it alongside subscription data and other research for informed decision-making.

How to Apply for Shanmuga Hospital Limited IPO

1

Login to Your Trading App

Open Zerodha, Upstox, Groww, Angel One, or any brokerage app.

2

Go to IPO Section

Find Shanmuga Hospital Limited under the IPO section. Select it and enter your bid details — choose lot size and price (cut-off price recommended).

3

Enter UPI ID and Submit

Provide your UPI ID linked to your bank account and submit the application.

4

Approve Mandate on UPI App

Open your UPI app (Google Pay, PhonePe, Paytm, BHIM) and approve the IPO payment request.

5

Application Confirmed

Your funds will be blocked in your account until the IPO allotment process is completed.